Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 11/2015

01.11.2015 | Head and Neck

Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands

verfasst von: Charlotte S. Schouten, Otto S. Hoekstra, C. René Leemans, Jonas A. Castelijns, Remco de Bree

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Following failure of chemoradiotherapy (CRT) for advanced staged oropharyngeal squamous cell carcinomas (OPSCC), residual tumor can often be treated successfully with salvage surgery, if detected early. Current clinical practice in the VU University Medical Center is to perform routine response evaluation, i.e., examination under general anesthesia (EUA), 12 weeks after treatment. However, in the Netherlands there is no consensus on response evaluation in patients with advanced oropharyngeal cancer. Questionnaire on current clinical practice concerning response evaluation after CRT for advanced OPSCC in all eight head and neck cancer centers of the Dutch Head and Neck Oncology Cooperative Group. The response rate was 100 %. Response evaluation was routinely performed with various methods in five institutions (62.5 %) and in one institute (12.5 %) only if clinical evaluation was difficult. Two centers (25 %) did not perform response evaluation. In case of suspicion of residual disease during follow-up, six centers (75 %) performed imaging prior to EUA and two centers (25 %) only if clinical evaluation was difficult. Diagnostic techniques used prior to EUA were MRI (87.5 %), diffusion-weighted MRI (37.5 %), 18F-FDG-PET-CT (75–87.5 %) and CT (37.5 %). This survey shows a substantial variation in the diagnostic policy concerning response evaluation after CRT for advanced OPSCC in the Netherlands. There is a need for guidelines for response evaluation in patients with advanced oropharyngeal cancer.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917CrossRefPubMed
3.
Zurück zum Zitat Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709CrossRefPubMed Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695–1709CrossRefPubMed
4.
Zurück zum Zitat Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955CrossRefPubMed Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955CrossRefPubMed
5.
Zurück zum Zitat Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578CrossRefPubMed Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578CrossRefPubMed
6.
Zurück zum Zitat Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS et al (2005) Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol 28:385–392CrossRefPubMed Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS et al (2005) Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol 28:385–392CrossRefPubMed
7.
Zurück zum Zitat Roosli C, Studer G, Stoeckli SJ (2010) Salvage treatment for recurrent oropharyngeal squamous cell carcinoma. Head Neck 32:989–996CrossRefPubMed Roosli C, Studer G, Stoeckli SJ (2010) Salvage treatment for recurrent oropharyngeal squamous cell carcinoma. Head Neck 32:989–996CrossRefPubMed
8.
Zurück zum Zitat Valentino J, Spring PM, Shane M, Arnold SM, Regine WF (2002) Interval pathologic assessments in patients treated with concurrent hyperfractionated radiation and intraarterial cisplatin (HYPERRADPLAT). Head Neck 24:539–544CrossRefPubMed Valentino J, Spring PM, Shane M, Arnold SM, Regine WF (2002) Interval pathologic assessments in patients treated with concurrent hyperfractionated radiation and intraarterial cisplatin (HYPERRADPLAT). Head Neck 24:539–544CrossRefPubMed
9.
Zurück zum Zitat De Bree R, van der Putten L, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR (2009) Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol 45:386–393CrossRefPubMed De Bree R, van der Putten L, Brouwer J, Castelijns JA, Hoekstra OS, Leemans CR (2009) Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol 45:386–393CrossRefPubMed
10.
Zurück zum Zitat Klabbers BM, Lammertsma AA, Slotman BJ (2003) The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer. Mol Imaging Biol 5:257–270CrossRefPubMed Klabbers BM, Lammertsma AA, Slotman BJ (2003) The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer. Mol Imaging Biol 5:257–270CrossRefPubMed
11.
12.
Zurück zum Zitat Ross BD, Moffat BA, Lawrence TS, Mukherji SK, Gebarski SS, Quint DJ et al (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2:581–587PubMed Ross BD, Moffat BA, Lawrence TS, Mukherji SK, Gebarski SS, Quint DJ et al (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2:581–587PubMed
13.
Zurück zum Zitat Wong LY, Wei WI, Lam LK, Yuen AP (2003) Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 25:953–959CrossRefPubMed Wong LY, Wei WI, Lam LK, Yuen AP (2003) Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 25:953–959CrossRefPubMed
14.
Zurück zum Zitat Ojiri H, Mendenhall WM, Mancuso AA (2002) CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6–8 weeks after definitive radiotherapy as predictors of primary site control. Int J Radiat Oncol Biol Phys 52:748–754CrossRefPubMed Ojiri H, Mendenhall WM, Mancuso AA (2002) CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6–8 weeks after definitive radiotherapy as predictors of primary site control. Int J Radiat Oncol Biol Phys 52:748–754CrossRefPubMed
15.
Zurück zum Zitat Van den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, Balm AJ (2006) Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia? Cancer 106:1722–1729CrossRefPubMed Van den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, Balm AJ (2006) Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia? Cancer 106:1722–1729CrossRefPubMed
16.
Zurück zum Zitat Nomayr A, Lell M, Sweeney R, Bautz W, Lukas P (2001) MRI appearance of radiation-induced changes of normal cervical tissues. Eur Radiol 11:1807–1817CrossRefPubMed Nomayr A, Lell M, Sweeney R, Bautz W, Lukas P (2001) MRI appearance of radiation-induced changes of normal cervical tissues. Eur Radiol 11:1807–1817CrossRefPubMed
17.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed
18.
Zurück zum Zitat Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N et al (2003) Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67 Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44:198–206PubMed Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N et al (2003) Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67 Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44:198–206PubMed
19.
Zurück zum Zitat Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE et al (2009) Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 27:2509–2515PubMedCentralCrossRefPubMed Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE et al (2009) Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 27:2509–2515PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG et al (2009) 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med 50:1940–1947CrossRefPubMed Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG et al (2009) 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med 50:1940–1947CrossRefPubMed
21.
Zurück zum Zitat Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG et al (2010) FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 37:181–200PubMedCentralCrossRefPubMed Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG et al (2010) FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 37:181–200PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Yamamoto Y, Wong TZ, Turkington TG, Hawk TC, Coleman RE (2007) Head and neck cancer: dedicated FDG PET/CT protocol for detection–phantom and initial clinical studies. Radiology 244:263–272CrossRefPubMed Yamamoto Y, Wong TZ, Turkington TG, Hawk TC, Coleman RE (2007) Head and neck cancer: dedicated FDG PET/CT protocol for detection–phantom and initial clinical studies. Radiology 244:263–272CrossRefPubMed
23.
Zurück zum Zitat Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR et al (2009) Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med 50:1205–1213CrossRefPubMed Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR et al (2009) Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med 50:1205–1213CrossRefPubMed
24.
Zurück zum Zitat Lindholm H, Johansson O, Jonsson C, Jacobsson H (2012) The distribution of FDG at PET examinations constitutes a relative mechanism: significant effects at activity quantification in patients with a high muscular uptake. Eur J Nucl Med Mol Imaging 39:1685–1690CrossRefPubMed Lindholm H, Johansson O, Jonsson C, Jacobsson H (2012) The distribution of FDG at PET examinations constitutes a relative mechanism: significant effects at activity quantification in patients with a high muscular uptake. Eur J Nucl Med Mol Imaging 39:1685–1690CrossRefPubMed
25.
Zurück zum Zitat Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT et al (2008) The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 35:2320–2333CrossRefPubMed Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT et al (2008) The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 35:2320–2333CrossRefPubMed
26.
Zurück zum Zitat Parysow O, Mollerach AM, Jager V, Racioppi S, San RJ, Gerbaudo VH (2007) Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med 32:351–357CrossRefPubMed Parysow O, Mollerach AM, Jager V, Racioppi S, San RJ, Gerbaudo VH (2007) Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med 32:351–357CrossRefPubMed
27.
Zurück zum Zitat Agrawal A, Nair N, Baghel NS (2009) A novel approach for reduction of brown fat uptake on FDG PET. Br J Radiol 82:626–631CrossRefPubMed Agrawal A, Nair N, Baghel NS (2009) A novel approach for reduction of brown fat uptake on FDG PET. Br J Radiol 82:626–631CrossRefPubMed
28.
Zurück zum Zitat King AD, Mo FK, Yu KH, Yeung DK, Zhou H, Bhatia KS et al (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20:2213–2220CrossRefPubMed King AD, Mo FK, Yu KH, Yeung DK, Zhou H, Bhatia KS et al (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20:2213–2220CrossRefPubMed
29.
Zurück zum Zitat Vandecaveye V, Dirix P, De KF, de Op BK, Vander PV, Hauben E et al (2012) Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82:1098–1107CrossRefPubMed Vandecaveye V, Dirix P, De KF, de Op BK, Vander PV, Hauben E et al (2012) Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82:1098–1107CrossRefPubMed
30.
Zurück zum Zitat Abdel Razek AA, Kandeel AY, Soliman N, El-shenshawy HM, Kamel Y, Nada N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152CrossRefPubMed Abdel Razek AA, Kandeel AY, Soliman N, El-shenshawy HM, Kamel Y, Nada N et al (2007) Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 28:1146–1152CrossRefPubMed
31.
Zurück zum Zitat Tshering Vogel DW, Zbaeren P, Geretschlaeger A, Vermathen P, De KF, Thoeny HC (2013) Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol 23:562–569CrossRefPubMed Tshering Vogel DW, Zbaeren P, Geretschlaeger A, Vermathen P, De KF, Thoeny HC (2013) Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers. Eur Radiol 23:562–569CrossRefPubMed
32.
Zurück zum Zitat Vandecaveye V, De KF, Nuyts S, Deraedt K, Dirix P, Hamaekers P et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971CrossRefPubMed Vandecaveye V, De KF, Nuyts S, Deraedt K, Dirix P, Hamaekers P et al (2007) Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys 67:960–971CrossRefPubMed
33.
Zurück zum Zitat Isles MG, McConkey C, Mehanna HM (2008) A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 33:210–222CrossRefPubMed Isles MG, McConkey C, Mehanna HM (2008) A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 33:210–222CrossRefPubMed
34.
Zurück zum Zitat Kapoor V, Fukui MB, McCook BM (2005) Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls. AJR Am J Roentgenol 184:589–597CrossRefPubMed Kapoor V, Fukui MB, McCook BM (2005) Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls. AJR Am J Roentgenol 184:589–597CrossRefPubMed
Metadaten
Titel
Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands
verfasst von
Charlotte S. Schouten
Otto S. Hoekstra
C. René Leemans
Jonas A. Castelijns
Remco de Bree
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 11/2015
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-014-3389-4

Weitere Artikel der Ausgabe 11/2015

European Archives of Oto-Rhino-Laryngology 11/2015 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.